Gentian Diagnostics AS (OSL:GENT) FCF Yield % : 0.32 (As of Apr. 26, 2025)

View and export this data going back to 2016. Start your Free Trial

What is Gentian Diagnostics AS FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Gentian Diagnostics AS's Trailing 12-Month Free Cash Flow is kr2.5 Mil, and Market Cap is kr763.4 Mil. Therefore, Gentian Diagnostics AS's FCF Yield % for today is 0.32%.

The historical rank and industry rank for Gentian Diagnostics AS's FCF Yield % or its related term are showing as below:

OSL:GENT' s FCF Yield % Range Over the Past 10 Years
Min: -7.45 Med: -2.83 Max: 3.48
Current: 0.32

During the past 12 years, the highest FCF Yield % of Gentian Diagnostics AS was 3.48%. The lowest was -7.45%. And the median was -2.83%.

OSL:GENT's FCF Yield % is ranked better than
58.89% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: -1.74 vs OSL:GENT: 0.32

Gentian Diagnostics AS's FCF Margin % for the quarter that ended in Dec. 2024 was -17.25%.

Gentian Diagnostics AS FCF Yield % Historical Data

The historical data trend for Gentian Diagnostics AS's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gentian Diagnostics AS FCF Yield % Chart

Gentian Diagnostics AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

Get a 7-Day Free Trial

-2.26

-3.59

-4.53

1.71

0.41

Gentian Diagnostics AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial															7.59	-0.42	-1.57	8.22	-4.86

Competitive Comparison of Gentian Diagnostics AS's FCF Yield %

For the Medical Devices subindustry, Gentian Diagnostics AS's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gentian Diagnostics AS's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gentian Diagnostics AS's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Gentian Diagnostics AS's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Gentian Diagnostics AS FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Gentian Diagnostics AS's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	2.507	/	604.5424
	=	0.41%

Gentian Diagnostics AS's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-7.352	*	4	/	604.5424
	=	-4.86%

Gentian Diagnostics AS FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Gentian Diagnostics AS FCF Yield % Related Terms

Thank you for viewing the detailed overview of Gentian Diagnostics AS's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gentian Diagnostics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gentian Diagnostics AS (OSL:GENT) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bjornasveien 5, Moss, NOR, 1596

Website

https://www.gentian.com

Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.